Alaunos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 30.06 K | $97.10 K | 43.34% | 1.38% |
| BLACKROCK, INC. | 02/12/2026 | 21.35 K | $68.97 M | 0.00% | 0.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 19.74 K | $63.76 K | 24.98% | 0.90% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 18.59 K | $60.04 K | 100.00% | 0.85% |
| HRT FINANCIAL LP | 02/12/2026 | 12.60 K | $40.00 K | 100.00% | 0.58% |
| MORGAN STANLEY | 02/13/2026 | 1.65 K | $5.32 K | -2.20% | 0.08% |
| UBS GROUP AG | 01/29/2026 | 1.31 K | $4.23 K | -14.61% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.08 K | $3.49 K | -33.80% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 1.08 K | $3.47 K | -7.64% | 0.05% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 300 | $969 | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 178 | $574 | -2.73% | 0.01% |
| RONALD BLUE TRUST, INC. | 01/16/2026 | 135 | $436 | 0.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 92 | $297.00 K | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 89 | $287 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 89 | $287 | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 70 | $226.00 K | 0.00% | 0.00% |
| KEY FINANCIAL INC | 02/09/2026 | 24 | $78 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 01/20/2026 | 23 | $74 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/21/2026 | 21 | $68 | -12.50% | 0.00% |
| NBC SECURITIES, INC. | 01/29/2026 | 20 | $64 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 01/20/2026 | 19 | $61 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 6 | $19 | 0.00% | 0.00% |
| TIDEMARK, LLC | 02/10/2026 | 2 | $6 | 100.00% | 0.00% |
| TUCKER ASSET MANAGEMENT LLC | 02/05/2026 | 1 | $3 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ASSET DEDICATION, LLC | 01/26/2026 | 0 | $0 | -100.00% | 0.00% |
| WEALTHSPIRE ADVISORS, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
Alaunos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of Alaunos Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD GROUP INC: 30,061
BlackRock, Inc.: 21,353
GEODE CAPITAL MANAGEMENT, LLC: 19,736
TWO SIGMA INVESTMENTS, LP: 18,588
HRT FINANCIAL LP: 12,602
MORGAN STANLEY: 1,647
1.45% of Alaunos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 13.80 M shares in the last 24 months. This purchase volume represents approximately $35.19 M in transactions.